Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 7 of 7

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2007

Intravitreal Bevacizumab as an Adjunct to Ovine Hyaluronidase (Vitrase®) in the Long-Term Management of Vitreous Hemorrhage

A. Toor; D. Chruscicki; A. Macedo; R. L. Lieberman; R. M. Fischer

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):265.

ARVO Annual Meeting Abstract May 2007

Long-Term Follow-Up of HIV-Positive Patients With Infectious Posterior Ophthalmic Disease in a City Hospital Population

S. Hsieh; R. M. Lieberman; D. A. Chruscicki; A. Toor; N. N. Vaidya; S. R. Oh; K. J. Zamecki; R. M. Fischer

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):340.

ARVO Annual Meeting Abstract May 2007

The Use of Ovine Hyaluronidase (Vitrase®) in Non-Clearing Vitreous Hemorrhage of Varying Durations

D. A. Chruscicki; S. Hsieh; A. G. Nagpal; A. Toor; R. Radhakrishnan; N. N. Vaidya; S. Oh; R. M. Lieberman; R. M. Fischer

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1399.

ARVO Annual Meeting Abstract May 2004

The Additivity of Pilocarpine to Bimatoprost in Early Glaucoma and Ocular Hypertension

A. Toor; M.M. Fahim; L.A. Polikoff; R.A. Chanis; A.P. Sinha; J.B. Serle

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):5566.

ARVO Annual Meeting Abstract May 2004

The Effect of Weightlifting On Intraocular Pressure In Glaucoma Patients

L.A. Polikoff; M. Fahim; R. Chanis; A. Toor; J. Serle

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):967.

ARVO Annual Meeting Abstract May 2004

The Effect of Varying Dosing Interval on the Efficacy of Intraocular Pressure Lowering Drugs

J.B. Serle; A. Toor; M.M. Fahim; L.A. Polikoff; J. Ellison

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):971.

ARVO Annual Meeting Abstract May 2004

Comparison of Scanning Laser Tomography and Humphrey Visual Field Analysis to Determine Progression in Glaucoma Patients

M.M. Fahim; A. Toor; A. Sleem; S. Bernardo; L.A. Polikoff; D. Gill; J.B. Serle

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):3351.

Advertisement